ARO-APOC3
arrowhead pharmaceuticals
['arrowhead']
we re live now wrapping up our #aha22 presentation set with phase 2 data on our investigational #rnai therapeutic for patients with #severehypertriglyceredemia. learn more here if you're not able to join live: 
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.